Summary
Two theories have been put forth concerning the anxiolytic actions of the anti-anxiety drugs. One theory maintains that these drugs decrease locus coeruleus output, and the other maintains that they facilitate gammaaminobutyric acid (GABA) neurotransmission at benzodiazepine (BZ)-linked GABA receptors. The BZ-anxiolytic diazepam does decrease locus coeruleus neuronal impulse flow. However, this decrease is not due to effects on BZ-linked GABA receptors in the locus coeruleus. Furthermore, the non-BZ anxiolytic buspirone, its metabolite and its analog all slightly increase locus coeruleus neuronal impulse flow. This increase, in the case of the metabolite, appears to be due, in part, to blockade ofα 2-adrenoceptors. Finally, buspirone, unlike diazepam, did not potentiate GABA inhibition at BZ-linked GABA receptor sites (i.e. cerebellar Purkinje cells). These data suggest that the non-BZ anxiolytic buspirone produces its anti-anxiety effects by unconventional mechanisms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Braestrup, C., Albrechtsen, R., Squires, R. F.: High densities of benzodiazepine receptors in human cortical areas. Nature269, 702–704 (1977).
Caccia, S., Garattini, S., Mancinelli, A., Muglia, M.: Identification and quantitation of 1-(2-pyrimidinyl) piperazine, an active metabolite of the anxiolytic agent buspirone, in rat plasma and brain. J. Chromat.252, 310–314 (1982).
Cedarbaum, J. M., Aghajanian, G. K.: Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur. J. Pharmacol.44, 375–385 (1977).
Cedarbaum, J. M., Aghajanian, G. K.: Activation of locus coeruleus neurons by peripheral stimuli: modulation by a collateral inhibitory mechanism. Life Sci.23, 1383–1392 (1978).
Costa, E., Guidotti, A., Mao, C.: Evidence for the involvement of GABA in the action of benzodiazepines: Studies in rat cerebellum. In: Advances in Biochemical Psychopharmacology (Costa, E., Greengard, P., eds.), pp. 113–130. Raven Press. 1975 a.
Costa, E., Guidotti, A., Mao, C. C., Suria, A.: New concepts on the mechanism of action of benzodiazepines. Life Sci.17, 167–186 (1975 b).
Eccles, J. C., Ito, M., Szentagothai, J.: The cerebellum as a neuronal machine. Berlin-Heidelberg-New York: Springer. 1967.
Eison, M. S., Taylor, D. P., Riblet, L. M., New J. S., Temple, D. L., Yevich J. P.: MJ-13805-1: A potential non-benzodiazepine anxiolytic. Neurosci. Abstr.470 (1982).
Garattini, S., Caccia, S., Mennini, T.: Notes on Buspirone's mechanism of action. J. Clin. Psychiat.43, 12 (2) 19–22 (1982).
German, D. C., Sanghera, M. K., Kiser, R. S., McMillen, B. A., Shore, P. A.: Electrophysiological and biochemical responses of noradrenergic neurons to a nonamphetamine CNS stimulant. Brain Res.166, 331–339 (1979).
Gold, M. S., Redmond, D. E., Kleber, H. D.: Clonidine blocks acute opiatewithdrawal symptoms. Lancet1978, 599–601.
Grant, S. J., Huang, Y. H., Redmond, D. E.: Benzodiazepines attenuate single unit activity in the locus coeruleus. Life Sci.27, 2231–2236 (1980).
Guidotti, A.: Interaction between benzodiazepines and GABA receptors: A base for the therapeutic action of benzodiazepines. In: Neuroreceptors-Basic and Clinical Aspects (Usdin, E., Bunney, W. E., Davis, J. M., eds.), pp. 189–197. J.Wiley. 1981.
Haefely, W., Kulscar, A., Mohler, H., Pieri, L., Polc, P., Schaffner, R.: Possible involvement of GABA in the central actions of benzodiazepines. In: Advances in Biochemical Psychopharmacology (Costa, E., Greengard, P., eds.), Vol. 12, pp.131–151. Raven Press. 1975.
Haefely, W., Polc, P., Pieri, L., Schaffner, R.: Effects of benzodiazepines on the electrical activity of the central nervous system: corelation with synaptic pharmacology. In: Neuro-Psychopharmacology (Saletu, B., Berner, B., Hollister, L., eds.), pp. 449–458. Pergamon Press. 1979 a.
Haefely, W., Polc, P., Schaffner, R., Keller, H. H., Pieri, L., Mohler, H.: Facilitation of GABAergic transmission by drugs. In: GABA-neurotransmitters: Pharmaco-chemical, Biochemical and Pharmacological Aspects (Krogsgaarol-Larsen, P., Scheel-Keuger, J., Kofod, H., eds.), pp. 357–375. Munksgaard. 1979 b.
Hoehn-Saric, R., Merchant, A. F., Keyser, M. L., Smith, V. K.: Effects of clonidine on anxiety disorders. Arch. Gen. Psychiat.38, 1278–1282 (1981).
Iversen, L. L., Schon, F.: The use of autoradiographic techniques for the identification and mapping of transmitter-specific neurons in the CNS. In: New Concepts of Transmitter Regulation (Mandell, A., Segal, D., eds.), pp. 153–193. Plenum Press. 1973.
Leeb-Lundberg, F., Snowman, A., Olsen, R.: Barbiturate receptor sites are coupled to benzodiazepine receptors. Proc. Natl. Acad. Sci. U.S.A.77, 7468–7472 (1980).
Mao, C. C., Guidotti, A., Costa, E.: Evidence for an involvement of GABA in the mediation of the cerebellar cGMP decrease and the anticonvulsant action of diazepam. Naunyn-Schmiedeberg's Arch. Pharmacol.289, 369–378 (1975).
McMillen, B. A., Matthews, R. T., Sanghera, M. K., Shepard, P. D., German, D. C.: Dopamine receptor antagonism by the novel anti-anxiety drug, buspirone. J. Neurosci.3, 733–738 (1983).
Paul, S., Marangos, P., Skolnick, P.: The benzodiazepines-GABA-chloride-ionophore receptor complex: common site of minor tranquilizer action. Bio. Psychiat.16, 213–229 (1981).
Paul, S. M., Skolnick, P.: Comparative neuropharmacology of antianxiety drugs. Pharmacol. Biochem. & Behav.17, Suppl. 1, 37–41 (1982).
Redmond, D. E.: Alteration in the function of the nucleus locus coeruleus: a possible model for studies of anxiety. In: Animal Models in Psychiatry and Neurology (Hanin, I., Usdin, E., eds.), pp. 293–304. Pergamon Press. 1977.
Redmond, D. E., Huang, Y. H.: New evidence for a locus coeruleus norepinephrine connection with anxiety. Life Sci.25, 2149–2162 (1979).
Redmond, D. E., Huang, Y. H., Synder, D. R., Maas J. W.: Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-tailed monkey Macaca arctoides. Brain Res.116, 502–510 (1976 a).
Redmond, D. E., Huang, Y. H., Synder, D. R., Baulu, J., Maas, J. W.: Behavioral changes following lesions of the locus coeruleus in Macaca Arctoides. Neurosci. Abstr.1976b, 668.
Riblet, L. A., Taylor, D. P., Eison, M. S., Stanton, H. C.: Pharmacology and Neurochemistry of Buspirone. J. Clin. Psychiat.43, 12 (2), 11–16 (1982).
Sanghera, M. K., McMillen, B. A., German, D. C.: Buspirone, a non-benzodia-zepine anxiolytic, increase locus coeruleus noradrenergic neuronal activity. Eur. J. Pharmacol.86, 107–110 (1982).
Skolnick, P., Paul, S., Barker, J.: Pentobarbital potentiates GABA-enhanced (3H) diazepam binding to benzodiazepine receptors. Eur. J. Pharmacol.65, 125–127 (1980).
Skolnick, P., Rice, K., Barker, J., Paul, S.: Interaction of barbiturates with benzodiazepine receptors in the central nervous system. Brain Res.233, 143–156 (1982).
Stanton, H. C., Taylor, D. P., Riblet, L. A.: Buspirone-An anxioselective drug with dopaminergic action. In: The Neurobiology of the Nucleus Accumbens (Chronister, R. B., DeFrance, J. F., eds.), pp. 316–321. 1981.
Supavilai, P., Karobath, M.: The effects of temperature and chloride ions on the stimulation of (3H) flunitrazepam binding by the muscimol analogues THIP and piperdine-4-sulfonic acid. Neurosci. Lett.19, 337–341 (1980).
Tallman J., Thomas, J., Gallager, D.: GABAergic modulation of benzodiazepine binding site sensitivity. Nature274, 383–385 (1978).
Tollman, J., Paul, P., Skolnick, P., Gallager, D.: Receptors for the age of anxiety: molecular pharmacology of the benzodiazepines. Science207, 274–281 (1980).
Tasaki, K., Tsukakaro, U., Ito, S., Wayner, M. J., Yu, W. Y.: A simple direct and rapid method for filling microelectrodes. Physiol. Behav.3, 1009–1011 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sanghera, M.K., German, D.C. The effects of benzodiazepine and non-benzodiazepine anxiolytics on locus coeruleus unit activity. J. Neural Transmission 57, 267–279 (1983). https://doi.org/10.1007/BF01248998
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01248998